Turn Therapeutics TTRX
NASDAQ TTRX
$13.41 +0.37 (+2.84%)
At close: Sep 29, 2026 · 4:00 PM EDT

Turn Therapeutics (TTRX) Restructuring Costs (2025 - 2026)

Updated

Turn Therapeutics' Restructuring Costs was $286,126 in Q1 2026, up 153.4% from $112,931 a year earlier.

Analysis

Turn Therapeutics (TTRX) Restructuring Costs (2025 - 2026) Analysis & Trends

For FY2025, Restructuring Costs at Turn Therapeutics came in at $928,562, up 190.0% from FY2024.

  • In earlier years, Restructuring Costs was $320,176 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Turn Therapeutics 388.44 Mn 388.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 286,126.00
Mar 31, 2025 112,931.00
API Access

Turn Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=TTRX&period=max&api_key=YOUR_API_KEY